Hepatobiliary disposition in primary cultures of dog and monkey hepatocytes

Molecular Pharmaceutics

Volumn 3, Issue 3, 2006, Pages 266-274

  Rose, Kelly A ^a   Kostrubsky, Vsevolod ^b   Sahi, Jasminder ^a,c  

^a Department of Pharmacokinetics Pharmacodynamics and Metabolism ^*  (United States)

^b PFIZER INC   (United States)

^c CellzDirect   (United States)

Author keywords

Biliary excretion; Bsep; Drug transport model; Hepatic uptake; Hepatocytes

Indexed keywords

COLLAGEN; CYCLOSPORIN A; GLIBENCLAMIDE; SALICYLIC ACID; TAUROCHOLIC ACID; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; BILIARY EXCRETION; CELL STRUCTURE; CONTROLLED STUDY; DOG; DRUG DISPOSITION; DRUG ELIMINATION; DRUG INHIBITION; DRUG SAFETY; DRUG TRANSPORT; DRUG UPTAKE; HEPATOBILIARY SYSTEM; INTRAHEPATIC BILE DUCT; LIVER CELL CULTURE; LIVER FUNCTION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CELL CULTURE TECHNIQUES; COLLAGEN; CYCLOSPORINE; DOGS; EXTRACELLULAR MATRIX; GLYBURIDE; HAPLORHINI; HEPATOCYTES; METABOLIC DETOXICATION, DRUG; SALICYLIC ACID; SPECIES SPECIFICITY; TAUROCHOLIC ACID;

EID: 33745813955     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0501022     Document Type: Article

References (25)

1. LeCluyse, E.; Audus, K.; Hochman, J. Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am. J. Physiol.: Cell Physiol. 1994, 35, C1764-C1774.
2. Liu, X.; LeCluyse, E.; Brouwer, K.; Gan, L.; Lemasters, J.; Steiger, B.; Meier, P.; Brouwer, K. Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am. J. Physiol.: Gastrointest. Liver Physiol. 1999, 40, G12-G21.
3. Annaert, P.; Turncliff, R.; Booth, C.; Thakker, D.; Brouwer, K. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab. Dispos. 2001, 29, 1277-1283.
4. Kostrubsky, V. E.; Strom, S. C.; Hanson, J.; Urda, E.; Rose, K.; Burliegh, J.; Zocharski, P.; Cai, H.; Sinclair, J. F.; Sahi, J. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol. Sci. 2003, 76 (1), 220-228.
5. van Montfoort, J.; Heagenbuch, B.; Groothuis, G.; Koepsell, H.; Peier, P.; Meijer, D. Drug uptake systems in liver and kidney. Curr. Drug Metab. 2003, 4, 185-211.
6. Shitara, Y.; Itoh, T.; Sato, H.; Li, A. P.; Sugiyama, Y. Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J. Pharmacol. Exp. Ther. 2003, 304, 610-616.
7. Fattinger, K.; Funk, C.; Pantze, M.; Weber, C.; Reichen, J.; Stieger, B.; Meier, P. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions. Clin. Pharmacol. Ther. 2001, 69, 223-231.
8. Kadmon, M.; Klunemaan, C.; Bohme, M.; Ishikawa, T.; Gorgas, K.; Otto, G.; Herfarth, C.; Keppler, D. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology 1993, 104, 1507-1514.
9. Bolder, U.; Trang, N.; Hagey, L.; Schteingart, C.; Ton-Nu, H.; Cerre, C.; Elferink, R.; Hofmann, A. Sunlidac is excreted into bile by a canalicular bile salt pump and undergoes cholehepatic circulation in rats. Gastroenterology 1999, 117, 962-971.
10. Stieger, B.; Fattinger, K.; Madon, J.; Kullak-Ublick, G.; Meier, P. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (bsep) of rat liver. Gastroenterology 2000, 118, 422-430.
11. Crocenzi, F. A.; Basiglio, C. L.; Perez, L. M.; Portesio, M. S.; Pozzi, E. J.; Roma, M. G. Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP. Biochem. Pharmacol. 2005, 69 (7), 1113-1120.
12. Rose, K.; Hurst, S.; Weller, D.; Lou, Z.; Han, H.-K.; Sahi, J. Utilization of sandwich cultures art, dog, monkey and human hepatocytes to evaluate biliary clearance. Drug Metab. Rev. 2004, 36, 682.
13. Liu, X.; Chism, J. P.; LeCluyse, E. L.; Brouwer, K. R.; Brouwer, K. L. Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab. Dispos. 1999, 27 (6), 637-644.
14. Liu, X.; LeCluyse, E. L.; Brouwer, K. R.; Lightfoot, R. M.; Lee, J. I.; Brouwer, K. L. Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 1999, 289 (3), 1592-1599.
15. Liu, X.; Brouwer, K. L.; Gan, L. S.; Brouwer, K. R.; Stieger, B.; Meier, P. J.; Audus, K. L.; LeCluyse, E. L. Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a collagen sandwich configuration. Pharm. Res. 1998, 15 (10), 1533-1539.
16. Faber, K.; Muller, M.; Jansen, P. Drug transport proteins in the liver. Adv. Drug Delivery Rev. 2003, 55, 107-124.
17. Klintmalm, G.; Iwatsuki, S.; Starzl, T. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981, 32, 488-489.
18. Kusuhara, H.; Sugiyama, Y. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J. Controlled Release 2002, 78, 43-54.
19. Sahi, J. Use of in vitro Transporter Assays to Understand Hepatic and Renal Disposition of New Drug Candidates. Expert Opin. Drug Metab. Toxicol. 2005, 1, 409-427.
20. Mizuno, N.; Niwa, T.; Yotsumoto, Y.; Sugiyama, Y. Impact of drug transporter studies on drug discovery and development. Pharm. Rev. 2003, 55, 425-461.
21. Lora, L.; Mazzon, E.; Martines, D.; Fries, W.; Muraca, M.; A., M.; d'Odorico, A.; Naccarato, R.; Citi, S. Hepatocyte tight-junctional permeability is increased in rat experimental colitis. Gastroenterology 1997, 113, 1347-1354.
22. Strautnieks, S.; Bull, L.; Knisely, A.; Dahl, N.; Arnell, H.; Sokal, E.; Dahan, K.; Childs, S.; Ling, V.; Tanner, M.; Kagalwalla, A.; Nemeth, A.; J., P.; Baker, A.; Mieli-Vergani, G.; Freimer, N.; Gardiner, R.; Thompson, R. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998, 20, 233-238.
23. Jansen, P.; Strautnieks, S.; Jacquemin, E.; Hadchouel, M.; Sokal, E.; Hooiveld, G.; Koning, J.; De Jager-Krikken, A.; Kuipers, F.; Stellaard, F.; Bijleveld, C.; Gouw, A.; Van Goor, H.; Thompson, R.; Muller, M. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999, 117, 1370-1379.
24. Ninuma, K.; Kato, Y.; Suzuki, H.; Tyson, C.; Weizer, V.; Dabbs, J.; Froehlich, R.; Green, C.; Sugiyama, Y. Primary active transport of organic anions on bile canalicular membrane in humans. Am. J. Physiol. 1999, 276, G1153-G1164.
25. Tiller, P.; Land, A.; Jardine, I.; Murphy, D.; Sozio, R.; Ayrton, A.; Schaefer, W. Application of liquid chromatography-mass spectrometry(n) analyses to the characterization of novel glyburide metabolites formed in vitro. J. Chromatogr. 1998, 794, 15-25.